The value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography for the treatment planning of malignant gliomas

Front Radiat Ther Oncol. 1999:33:37-42. doi: 10.1159/000061212.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Neoplasms / diagnostic imaging*
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / radiotherapy*
  • Female
  • Glioma / diagnostic imaging*
  • Glioma / metabolism
  • Glioma / radiotherapy*
  • Humans
  • Iodine Radioisotopes*
  • Magnetic Resonance Imaging / methods
  • Male
  • Methyltyrosines* / pharmacokinetics
  • Middle Aged
  • Prospective Studies
  • Radiopharmaceuticals* / pharmacokinetics
  • Radiotherapy Planning, Computer-Assisted / methods*
  • Tomography, Emission-Computed, Single-Photon / methods*

Substances

  • 3-iodo-O-methyl-alpha-methyltyrosine
  • Iodine Radioisotopes
  • Methyltyrosines
  • Radiopharmaceuticals